Distinguished Faculty

Emily ShacterEmily Shacter, Ph.D., Chief, Laboratory of Biochemistry, Division of Therapeutic Proteins, Office of Biotechnology Products, FDA/CDER/OPS, FDA

Graham McCartneyR. Graham McCartney, Ph.D., Technical Lead, Biotechnology, Eli Lilly

Jane RobinsonJane Robinson, Ph.D., Principal Scientist, Biotherapeutics, National Institute for Biological Standards and Control (NIBSC)

Ruth RodriguezRuth Cordoba–Rodriguez, Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA

Igor KaltashovIgor Kaltashov, Ph.D., Associate Professor, Chemistry, University of Massachusetts and Shire Human Genetic Therapies

Nadine RitterNadine M. Ritter, Ph.D., Senior CMC Consultant, Biologics Consulting Group, Inc.

Ewa MarszalEwa Marszal, Ph.D., Chemist, Laboratory of Plasma Derivatives, Division of Hematology, CBER, FDA

XuRong JiangXu-Rong Jiang, Ph.D., M.D., Associate Director, Analytical Biochemistry, MedImmune, LLC

Stacey TravigliaStacey Traviglia, Ph.D., Senior Scientist, Analytical Technology, Biogen Idec, Inc.

Marco ThomannMarco Thomann, Ph.D., Group Leader, Development Analytics, Roche Diagnostics GmbH

Philippe GilbertPhilippe-Alexandre Gilbert, Senior Scientist, MedImmune, Inc.

Gillian WoollettGillian R. Woollett, M.A., D.Phil., Chief Scientist, Engel & Novitt, LLP

Liming ShiLiming Shi, M.A., M.Sc., Senior Scientist, Bioanalytical Chemistry, Amylin Pharmaceuticals, Inc.

Chris HollowayChris Holloway, Ph.D., Group Director, Regulatory Affairs, ERA Consulting Group

Alain BeckAlain Beck, Ph.D., Head, Physico-Chemistry, Centre d'Immunologie, Pierre Fabre

Ron TaticekRon Taticek, Ph.D., Senior Director and Head, Commercial Product Quality Stewards, Biologics, Genentech, Inc.

Tina MorrisTina S. Morris, Ph.D., Vice President, Biologics and Biotechnology, USP

Aimee Cossins, Ph.D., Group Leader, Analytical & Formulation Development, Syntaxin Ltd.

Ziping WeiZiping Wei, Ph.D., Fellow, Analytical Biochemistry, MedImmune, Inc.

Pat CashPat Cash, Senior Director, Analytical Biochemistry, MedImmune, Inc.

Qin ZouQin Zou, Ph.D., Senior Principal Scientist, Analytical Research & Development, Pfizer, Inc.

Michele DoughertyMichele K. Dougherty, Ph.D., Product Quality Reviewer, Division of Monoclonal Antibodies, OBP/CDER/FDA

Alain BernardAlain Bernard, Ph.D., Vice President, Biopharmaceutical Process Sciences, UCB Group

John O'HararJohn O'Hara, Ph.D., Associate Director, Analytical Development, Biologicals, UCB-Celltech

Kathleen WilliamsKathleen M. Williams, Ph.D., Partner, Intellectual Property, Edwards, Angell, Palmer & Dodge LLP

Brian HarveyBrian Harvey, M.D., Ph.D., Vice President, US Regulatory Policy, Global Regulatory Affairs, Sanofi-Aventis

Yung HsiangYung-Hsiang Kao, Ph.D., Senior Scientist & Group Leader, Protein Analytical Chemistry, Genentech, Inc.

Christian ClaussLouis-Christian Clauss, Phar.D., IAE, RACS, Antheln Biomed, USA

John StultsJohn T. Stults, Ph.D., Director, Protein Analytical Chemistry-2, Genentech, Inc., a member of the Roche Group

Daniel HigaziDaniel Higazi, Ph.D., Scientist, Analytical Biochemistry, MedImmune Ltd.

Jette Wypych, Ph.D., Principal Scientist, Process and Product Development, Amgen, Inc.

Alfred PanAlfred Pan, Ph.D., Associate Director, Analytical and Process Technologies, MedImmune, LLC

Paul GilPaul J. Gil, Ph.D., Deputy Director, Global Regulatory Affairs, Bayer HealthCare

Kirstin Bislev Hansen, M.SC., Senior Regulatory Project Manager, Regulatory Affairs, Marketed Products, Novo Nordisk A/S

Keith Chidwick Keith Chidwick, Ph.D., Senior Pharmaceutical Assessor, Biologicals Unit, MHRA

By Series:
By Region: